Please wait...


Generic Name: entacapone (en TAK a pone)
Brand Name: Comtan
Physician reviewed Comtan patient information - includes Comtan description, dosage and directions.
  • Prescription Settings

Prices and coupons of Comtan

Current Location: 20149 (Ashburn)
Change Location?

Enter your zip code

Please wait while the prices are loaded...

Don’t see your pharmacy listed? Most pharmacies accept our discounts, so have your pharmacist enter this coupon to see if you will save money:

Drug Information:
When used with carbidopa and levodopa (Atamet, Parcopa, Sinemet), Comtan increases levels of levodopa in the body. Comtan is used together with carbidopa and levodopa to treat "wearing-off" symptoms of Parkinson's disease, such as stiffness, tremors, muscle spasms, and poor muscle control. Comtan may also be used for purposes not listed in this medication guide. Follow all directions on your medicine label and package. Tell each of your healthcare providers about all your medical conditions, allergies, and all medicines you use. Learn more

Comtan Side Effects

Comtan Side Effects

Note: This document contains side effect information about entacapone. Some of the dosage forms listed on this page may not apply to the brand name Comtan.

In Summary

Common side effects of Comtan include: urine discoloration. See below for a comprehensive list of adverse effects.

For the Consumer

Applies to entacapone: oral tablet

Along with its needed effects, entacapone (the active ingredient contained in Comtan) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor immediately if any of the following side effects occur while taking entacapone:

More common

  • Absence of or decrease in body movements
  • hyperactivity
  • increase in body movements
  • seeing, hearing, or feeling things that are not there
  • twisting
  • twitching
  • uncontrolled repetitive movements of the tongue, lips, face, arms, or legs

Less common

  • Cough or hoarseness
  • fever or chills
  • lower back or side pain
  • painful or difficult urination


  • Confusion
  • muscle cramps
  • pain
  • shortness of breath
  • stiffness
  • unusual tiredness or weakness

Some side effects of entacapone may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

More common

  • Abdominal or stomach pain
  • constipation
  • diarrhea
  • dizziness
  • nausea

Less common

  • Acid or sour stomach
  • anxiety
  • belching
  • bruising
  • burning feeling in the chest or stomach
  • difficult or labored breathing
  • dry mouth
  • heartburn
  • indigestion
  • irritability
  • loss of strength or energy
  • muscle pain or weakness
  • passing gas
  • restlessness
  • sleepiness or unusual drowsiness
  • small, red spots on the skin
  • stomach discomfort, upset, or tenderness
  • sweating increased
  • tightness in the chest
  • tremor
  • trouble sleeping
  • unusual or unpleasant (after) taste
  • unusual weak feeling

For Healthcare Professionals

Applies to entacapone: oral tablet

Nervous system

Very common (10% or more): Dyskinesia (up to 27%), hyperkinesia (10%)

Common (1% to 10%): Hypokinesia, dizziness, somnolence, taste perversion, aggravated parkinsonism, dystonia, headache, tremor

Frequency not reported: Falling asleep during activities of daily living

Postmarketing reports: Neuroleptic malignant syndrome

There were no cases of neuroleptic malignant syndrome during clinical trials. Since market introduction, there have been isolated cases, especially following abrupt reduction or discontinuation of this drug and other concomitant dopaminergic drugs.


Very common (10% or more): Nausea (up to 14%), diarrhea (up to 11%)

Common (1% to 10%): Abdominal pain, constipation, vomiting, dry mouth, dyspepsia, flatulence, gastritis, gastrointestinal disorders

Very rare (less than 0.01%): Anorexia

Postmarketing reports: Colitis

In clinical trials, diarrhea occurred in approximately 10% of patients. It was generally mild to moderate, but in 1.3% of people it was severe. Upon discontinuation, diarrhea generally resolved. There have been postmarketing reports of drug-induced microscopic colitis, primarily lymphocytic colitis.


Very common (10% or more): Urine discoloration (10%)


The most commonly reported adverse reactions included dyskinesia, urine discoloration, diarrhea, nausea, hyperkinesia, abdominal pain, vomiting, and dry mouth.


Common (1% to 10%): Dyspnea

Frequency not reported: Pulmonary fibrosis


Common (1% to 10%): Increased sweating

Rare (less than 0.1%): Erythematous, maculopapular rash

Very rare (less than 0.01%): Urticaria

Frequency not reported: Skin hair, beard, and nail discolorations


Common (1% to 10%): Back pain, falls, leg cramps

Postmarketing reports: Rhabdomyolysis

Isolated cases of rhabdomyolysis have occurred in patients treated with this drug. The complicated nature of these cases makes it difficult to determine the role this drug may have had. Rhabdomyolysis has been reported secondary to severe dyskinesias or neuroleptic malignant syndrome (NMS) in patients with Parkinson's disease.


Common (1% to 10%): Anxiety, insomnia, hallucinations, confusion, paranoia

Uncommon (0.1% to 1%): Agitation

Frequency not reported: Impulse control disorders including pathological gambling, increased libido, hypersexuality, compulsive spending or buying, binge eating and compulsive eating


Common (1% to 10%): Purpura, decreased hemoglobin

A clinically significant decrease in hemoglobin has been observed in 1.8% of patients. The underlying mechanism may involve decreased absorption of iron from the gastrointestinal tract.


Common (1% to 10%): Fatigue, asthenia, pain, vertigo


The incidence of myocardial infarction and other ischemic heart disease events was 0.43% and 1.54%, respectively, in an analysis of 13 double-blind studies involving 2082 patients.

Common (1% to 10%): Ischemic heart disease events other than myocardial infarction (e.g., angina pectoris, postural hypotension

Uncommon (0.1% to 1%): Myocardial infarction


Rare (less than 0.1%): Abnormal liver function tests

Postmarketing reports: Hepatitis with mainly cholestatic features

Editorial References and Review

Medically reviewed by BestRx Medical Team Last updated on 1/1/2020.

Source: Drugs.com Comtan